GLP1R and obesity due to melanocortin 4 receptor deficiency: Furthermore, we showed the antihypertensive effect of GLP-1R agonist in addition to and independently of well-established anti-diabetic and anti-obese effects, suggesting that GLP-1R agonist is beneficial especially to the hypertensive patients with diabetes and/or obesity.